Evidence map›Paper›PMID 37129267›Full record

ArticleBritish journal of haematology2023

Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia population.

Andrew Doan, Holly K T Huang, Ari J Hadar, Jemily Malvar, Teresa Rushing, Gordana Raca, Alexandra E Kovach, David R Freyer, Chintan Parekh, Jamie Stokke and 5 more

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Andrew DoanKeck School of Medicine, University of Southern California, Los Angeles, California, USA.ORCID 0000-0002-8362-549X
Holly K T HuangDavid Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Ari J HadarUniversity South Florida, Tampa, Florida, USA.
Jemily MalvarCancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California, USA.
Teresa RushingDepartment of Pharmacy, Children's Hospital Los Angeles, Los Angeles, California, USA.
Gordana RacaKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Alexandra E KovachKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
David R FreyerKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Chintan ParekhKeck School of Medicine, University of Southern California, Los Angeles, California, USA.ORCID 0000-0001-8100-9151
Jamie StokkeKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Leila C PoschKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Julie DaoDepartment of Pharmacy, Children's Hospital Los Angeles, Los Angeles, California, USA.
Deepa BhojwaniKeck School of Medicine, University of Southern California, Los Angeles, California, USA.ORCID 0000-0002-7559-7927
Paul GaynonKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Etan OrgelKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
University of Southern California · USChildren's Hospital of Los Angeles · USUniversity of California, Los Angeles · USUniversity of South Florida · US

Funding

USC/CHLA Summer Oncology Research Fellowship (SORF) Program for Medical StudentsR25CA225513 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI ANAT ERDREICH-EPSTEIN, WIJBE MARTIN KAST · 2019 to 2026
$1.7M
NCI NIH HHS R25 CA225513
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IdarubicinLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsChildCytarabineGranulocyte Colony-Stimulating FactorHumansVidarabineCytarabineGranulocyte Colony-Stimulating FactorIdarubicinVidarabine

Identifiers

PMID37129267
PMCPMC10330637
OpenAlexW4367669168

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.